Results 161 to 170 of about 11,649,511 (362)

DRUG ERUPTIONS FROM THE CLINICAL ASPECT [PDF]

, 1922
Fred Wise
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

The effect of lowered muscle temperature on the action of neuromuscular blocking drugs in man

, 1959
Thomas H. Cannard, Eleanor Zaimis
openalex   +2 more sources

Drug Treatment of Malaria [PDF]

, 1959
Arthur Adams
openalex   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

A Robust and Accurate Filter Paper-Based Dried Plasma Spot Method for Bictegravir Monitoring in HIV Therapy. [PDF]

Rapid Commun Mass Spectrom
Sathyanarayanan A, Arekal RN, Somashekara D.   +2 more
europepmc   +1 more source

Commercial Drug Growing in the United States in 1918**Read before Scientific Section, A. Ph. A., New York meeting, 1919. [PDF]

, 1919
W. W. Stockberger
openalex   +1 more source

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

Molecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon   +4 more
wiley   +1 more source

Potential Drug Dose-Specific Adverse Three-Drug Combinations: A US Insurance Claims Data-Based Study. [PDF]

Pharmacoepidemiol Drug Saf
Shi Y, Sun A, Chiang CW, Yang Y, Hunold KM, Xu J, Russo M, Caterino J, Eadon MT, Li L, Su J, Donneyong M, Zhang P.   +12 more
europepmc   +1 more source

DETECTION OF POISONS AND POWERFUL DRUGS [PDF]

, 1916
WILHELM AUTENREITH, William H. Warren
openalex   +1 more source